Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Minerva Chirurgica|January 1, 1992
[Caustic lesions of the upper digestive tract. Our experience]G M Drusco, P Guglielmelli, R A BarilliLeukemia|March 31, 2006
A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresisA M Vannucchi, A Pancrazzi, C Bogani, et al.Leukemia|May 23, 2008
Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisalA M Vannucchi, E Antonioli, P Guglielmelli, et al.Leukemia|June 22, 2011
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patientsA Pardanani, P Guglielmelli, T L Lasho, et al.Il Giornale Di Chirurgia|April 25, 2012
Does the nasogastric tube has a role in elective colo-rectal surgery?R Macarone Palmieri, P M Amodio, M Rizzello, et al.Blood Cancer Journal|March 14, 2015
Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trialA Pardanani, A Tefferi, P Guglielmelli, et al.Leukemia|July 13, 2007
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burdenA M Vannucchi, E Antonioli, P Guglielmelli, et al.Leukemia|March 13, 2014
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic valueA M Vannucchi, G Rotunno, N Bartalucci, et al.British Journal of Haematology|July 21, 2005
Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host diseaseP Rubegni, A Cuccia, P Sbano, et al.Leukemia|February 6, 2014
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patientsA Tefferi, P Guglielmelli, T L Lasho, et al.Pageof 3